Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Atassi

Showing results (141-150 of 186) with videos related to

Pageof 19
Sort By:
Chemical & Pharmaceutical Bulletin|June 20, 2001
Synthesis and cytotoxic activity of benzopyranoxanthone analogues of benzC Sittisombut, N Costes, S Michel, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1981
Phase I clinical trial with alpha 1,3,5- triglycidyl-s-triazinetrione (NSC-296934)M Piccart, M Rozencweig, P Dodion, et al.
Bioorganic & Medicinal Chemistry|October 13, 2001
Synthesis, cytotoxic activity, NMR study and stereochemical effects of some new pyrano[3,2-b]thioxanthen-6-ones and pyrano[2,3-c]thioxanthen-7-onesI K Kostakis, N Pouli, P Marakos, et al.
Journal of Medicinal Chemistry|June 23, 1999
Synthesis of 9-O-substituted derivatives of 9-hydroxy-5, 6-dimethyl-6H-pyrido[4,3-b]carbazole-1-carboxylic acid (2-(dimethylamino)ethyl)amide and their 10- and 11-methyl analogues with improved antitumor activityC Guillonneau, PierréA, Y Charton, et al.
International Journal of Oncology|May 14, 2011
Multidrug-resistance circumvention and inhibition of [h-3] azidopine photolabeling of p-glycoprotein by new dihydropyridine derivatives displaying a low-affinity for calcium channelsS Leonce, A Pierre, V Perez, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 24, 2001
Synthesis and cytotoxic activity of 2-dialkylaminoethylamino substituted xanthenone and thioxanthenone derivativesI Kostakis, K Ghirtis, N Pouli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Relationship between the cellular accumulation and the cytotoxicity of S12363, a new Vinca alkaloid derivativeA Pierré, V Pérez, S Léonce, et al.
Journal of Inorganic Biochemistry|December 1, 1985
The antitumor activity of di-n-butyltin(IV) glycylglycinate, and the correlation with the structure of dialkyltin(IV) glycylglycinates in solution studied by conductivity measurements and by infrared, nuclear magnetic resonance, and Mössbauer spectroscopic methodsG Ruisi, A Silvestri, M T Lo Guidice, et al.
Cancer Research|May 1, 1991
Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363A Pierré, L Kraus-Berthier, G Atassi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1H Malonne, S Farinelle, C Decaestecker, et al.
Pageof 19

Showing results (141-150 of 186) with videos related to

Sort By:
Pageof 19
Chemical & Pharmaceutical Bulletin|June 20, 2001
Synthesis and cytotoxic activity of benzopyranoxanthone analogues of benzC Sittisombut, N Costes, S Michel, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1981
Phase I clinical trial with alpha 1,3,5- triglycidyl-s-triazinetrione (NSC-296934)M Piccart, M Rozencweig, P Dodion, et al.
Bioorganic & Medicinal Chemistry|October 13, 2001
Synthesis, cytotoxic activity, NMR study and stereochemical effects of some new pyrano[3,2-b]thioxanthen-6-ones and pyrano[2,3-c]thioxanthen-7-onesI K Kostakis, N Pouli, P Marakos, et al.
Journal of Medicinal Chemistry|June 23, 1999
Synthesis of 9-O-substituted derivatives of 9-hydroxy-5, 6-dimethyl-6H-pyrido[4,3-b]carbazole-1-carboxylic acid (2-(dimethylamino)ethyl)amide and their 10- and 11-methyl analogues with improved antitumor activityC Guillonneau, PierréA, Y Charton, et al.
International Journal of Oncology|May 14, 2011
Multidrug-resistance circumvention and inhibition of [h-3] azidopine photolabeling of p-glycoprotein by new dihydropyridine derivatives displaying a low-affinity for calcium channelsS Leonce, A Pierre, V Perez, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 24, 2001
Synthesis and cytotoxic activity of 2-dialkylaminoethylamino substituted xanthenone and thioxanthenone derivativesI Kostakis, K Ghirtis, N Pouli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Relationship between the cellular accumulation and the cytotoxicity of S12363, a new Vinca alkaloid derivativeA Pierré, V Pérez, S Léonce, et al.
Journal of Inorganic Biochemistry|December 1, 1985
The antitumor activity of di-n-butyltin(IV) glycylglycinate, and the correlation with the structure of dialkyltin(IV) glycylglycinates in solution studied by conductivity measurements and by infrared, nuclear magnetic resonance, and Mössbauer spectroscopic methodsG Ruisi, A Silvestri, M T Lo Guidice, et al.
Cancer Research|May 1, 1991
Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363A Pierré, L Kraus-Berthier, G Atassi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1H Malonne, S Farinelle, C Decaestecker, et al.
Pageof 19